Marion Subklewe
Impact in
- Immunology top 0.5%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Oncology top 0.5%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
Papers in
- Oncology 102
- CAR-T cell therapy research 79
- Viral-associated cancers and disorders 15
- Immunology 75
- Immune Cell Function and Interaction 40
- Immunotherapy and Immune Responses 36
- Co-authors
- Ralph M. SteinmanNina BhardwajHans‐Joachim StemmlerFelix S. LichteneggerBoris BöllChristina KrupkaHans SchlößerPhilipp Gödel
- Journals
- Blood (40 papers)Leukemia (9 papers)HemaSphere (6 papers)Journal of Hematology & Oncology (5 papers)Cancer Immunology Immunotherapy (5 papers)
- Partner nations
- GermanyUnited StatesFrance
In The Last Decade
Marion Subklewe
160 papers receiving 8.3k citations
Hit Papers
Peers
Comparison fields: 5 of 137
- Immunology 3.9k
- Oncology 3.8k
- Hematology 1.5k
- Genetics 458
- Virology 196
Countries citing papers authored by Marion Subklewe
This map shows the geographic impact of Marion Subklewe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marion Subklewe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marion Subklewe more than expected).
Fields of papers citing papers by Marion Subklewe
This network shows the impact of papers produced by Marion Subklewe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marion Subklewe. The network helps show where Marion Subklewe may publish in the future.
Co-authors
The 25 scholars most cited alongside Marion Subklewe, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 14 | |
| 4 | 2024 | 29 | |
| 5 | 2024 | 33 | |
| 6 | 2024 | 8 | |
| 7 | 2023 | 17 | |
| 8 | 2023 | 1 | |
| 9 | 2023 | 20 | |
| 10 | 2023 | 4 | |
| 11 | 2023 | 39 | |
| 12 | 2023 | 24 | |
| 13 | 2022 | 19 | |
| 14 | 2022 | 1 | |
| 15 | 2019 | 64 | |
| 16 | 2017 | 1 | |
| 17 | 2017 | 9 | |
| 18 | Persistence of Driver Mutations during Complete Remission Associates with Shorter Survival and Contributes to the Inferior Outcomes of Elderly Patients with Acute Myeloid Leukemia | 2016 | 2 |
| 19 | Structures of the human and Drosophila 80S ribosome Hit paper breakdown → | 2013 | 448 |
| 20 | 2006 | 41 |
About Marion Subklewe
Marion Subklewe is a scholar working on Oncology, Immunology, Hematology, Pathology and Forensic Medicine and Genetics, having authored 167 papers that have together received 8.4k indexed citations. Recurring topics across this work include CAR-T cell therapy research (79 papers), Immune Cell Function and Interaction (40 papers), Immunotherapy and Immune Responses (36 papers), Acute Myeloid Leukemia Research (30 papers), Lymphoma Diagnosis and Treatment (21 papers), Viral-associated cancers and disorders (15 papers), Virus-based gene therapy research (12 papers) and RNA Interference and Gene Delivery (11 papers). The work is most often cited by research in Immunology (3.9k citations), Oncology (3.8k citations), Hematology (1.5k citations), Genetics (458 citations) and Virology (196 citations). Marion Subklewe has collaborated with scholars based in Germany, United States and France. Frequent co-authors include Ralph M. Steinman, Nina Bhardwaj, Hans‐Joachim Stemmler, Felix S. Lichtenegger, Boris Böll, Christina Krupka, Hans Schlößer, Philipp Gödel, Max Schlaak and Alexander Shimabukuro‐Vornhagen. Their work appears in journals such as Blood, Leukemia, HemaSphere, Journal of Hematology & Oncology and Cancer Immunology Immunotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.